Side-by-side comparison of AI visibility scores, market position, and capabilities
CFTC-designated contract market for event-based prediction futures, acquired by DraftKings in October 2025; YC W22-backed with ex-Point72 team achieving federal exchange status for hedging and prediction markets.
Railbird was an Austin, Texas-based CFTC-regulated prediction market exchange enabling businesses and traders to hedge commercial risk through event-based futures contracts — founded in 2021 and backed by Y Combinator (W22). Staffed by former Point72 analysts, Railbird achieved designated contract market (DCM) status from the CFTC in June 2025 (one of the first CFTC-regulated prediction market exchanges to receive full DCM designation) and was subsequently acquired by DraftKings in October 2025, bringing Railbird's regulated prediction market infrastructure into the sports betting giant's portfolio.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.